Selective Laser Trabeculoplasty (SLT) is an advanced non-thermal nanosecond laser treatment that has been clinically proven by the LiGHT trial to be a safe and effective first-line therapy for the treatment of primary open-angle glaucoma or ocular hypertension.1
Tango Reflex Neo by Ellex, a brand of Lumibird Medical, incorporates proprietary SLT technology, and delivers advanced energy control, a homogenous sharp-edged aiming beam, and the industry’s fastest firing rate of up to 4Hz – four shots per second.* This capability is being used every day by physicians worldwide to visualise the trabecular meshwork in greater detail, and to perform procedures faster and with improved accuracy, delivering better patient outcomes – reliably, accurately, and safely.
Visit: ellex.com
Reference
Gazzard, G., et al., Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial, The Lancet. doi.org/10.1016/S0140-6736(18)32213-X
*Based on system performance testing. Data on file. Ellex Medical.
